| ELEV Stock Yearly Return 2024 Table | ||||||||||||||||||||||||||||||
ELEV average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare ELEV average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| ELEV Share Performance |
| ELEV Stock Yearly Return 2024 Chart | |||
Also see: • ELEV YTD return • ELEV average annual return 10 years | |||
| About Elevation Oncology Inc |
| Elevation Oncology, Inc. is an oncology company. Co. is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. EO-3021 consists of a fully human immunoglobulin G1 (IgG1) mAb that targets Claudin 18.2 and is site-specifically conjugated to the monomethyl auristatin E (MMAE) payload via a cleavable linker with a drug-to-antibody ratio (DAR) of 2. The ELEV stock yearly return is shown above.
The yearly return on the ELEV stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2024 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the ELEV annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| ELEV Current Stock Quote |
 Free ELEV Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Elevation Oncology (ELEV) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
ELTX Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.
Video: Don't Forget Dividends in Average Annual Return!